CA2084640A1 - Compounds - Google Patents

Compounds

Info

Publication number
CA2084640A1
CA2084640A1 CA002084640A CA2084640A CA2084640A1 CA 2084640 A1 CA2084640 A1 CA 2084640A1 CA 002084640 A CA002084640 A CA 002084640A CA 2084640 A CA2084640 A CA 2084640A CA 2084640 A1 CA2084640 A1 CA 2084640A1
Authority
CA
Canada
Prior art keywords
compound
salt
alkyl
formula
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002084640A
Other languages
English (en)
French (fr)
Inventor
Yousuke Katsura
Tetsuo Tomishi
Yoshikazu Inoue
Hisashi Takasugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of CA2084640A1 publication Critical patent/CA2084640A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002084640A 1991-12-06 1992-12-04 Compounds Abandoned CA2084640A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919125970A GB9125970D0 (en) 1991-12-06 1991-12-06 New compounds
GB9125970.5 1991-12-06

Publications (1)

Publication Number Publication Date
CA2084640A1 true CA2084640A1 (en) 1993-06-07

Family

ID=10705819

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002084640A Abandoned CA2084640A1 (en) 1991-12-06 1992-12-04 Compounds

Country Status (14)

Country Link
US (1) US5532258A (enExample)
EP (1) EP0545376B1 (enExample)
JP (1) JP2531329B2 (enExample)
CN (1) CN1079469A (enExample)
AT (1) ATE170851T1 (enExample)
AU (1) AU666893B2 (enExample)
CA (1) CA2084640A1 (enExample)
DE (1) DE69226931T2 (enExample)
GB (1) GB9125970D0 (enExample)
HU (3) HU9203849D0 (enExample)
IL (1) IL103826A0 (enExample)
MX (1) MX9206930A (enExample)
TW (1) TW211565B (enExample)
ZA (1) ZA928876B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427539A1 (de) * 1994-08-04 1996-02-08 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von 2-Cyaniminothiazolidin
GB9416459D0 (en) * 1994-08-15 1994-10-05 Fujisawa Pharmaceutical Co New compounds
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
ATE227279T1 (de) 1995-12-29 2002-11-15 Boehringer Ingelheim Pharma Phenyl thiazol derivate mit antiherpesvirus eigenschaften
DE19719053A1 (de) * 1997-05-06 1998-11-12 Bayer Ag Substituierte Aminothiazole
US6100282A (en) 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
AU2002357137A1 (en) * 2001-12-10 2003-06-23 Bristol-Myers Squibb Company (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
CN116406816A (zh) * 2021-12-31 2023-07-11 湖南中烟工业有限责任公司 一种水溶性芯材烟用爆珠及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IT1200371B (it) * 1982-03-24 1989-01-18 Angeli Inst Spa Guanidino eterociclifenilamidine,processi per la loro preparazione e loro impiego farmaceutico
US4452985A (en) * 1983-02-14 1984-06-05 American Home Products Corporation 2-Guanyl-4-(substituted phenyl) thiazole derivatives

Also Published As

Publication number Publication date
MX9206930A (es) 1993-06-01
ZA928876B (en) 1993-07-15
US5532258A (en) 1996-07-02
DE69226931D1 (de) 1998-10-15
EP0545376A1 (en) 1993-06-09
AU666893B2 (en) 1996-02-29
JP2531329B2 (ja) 1996-09-04
ATE170851T1 (de) 1998-09-15
IL103826A0 (en) 1993-04-04
TW211565B (enExample) 1993-08-21
AU2983792A (en) 1993-06-10
HU9203849D0 (en) 1993-03-29
JPH06321921A (ja) 1994-11-22
DE69226931T2 (de) 1999-03-18
HUT65776A (en) 1994-07-28
HU211604A9 (en) 1995-12-28
EP0545376B1 (en) 1998-09-09
GB9125970D0 (en) 1992-02-05
CN1079469A (zh) 1993-12-15

Similar Documents

Publication Publication Date Title
AU656576B2 (en) Quinoline derivatives
US6426345B1 (en) Heterobicyclic derivatives
US5155101A (en) Tricyclic compounds
JPWO1994011375A1 (ja) 三環式化合物
US4596829A (en) 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
WO1992012154A1 (en) Imidazotriazine derivatives
US5322842A (en) Tricyclic benzodiazepine derivates, their preparation, and pharmaceutical compositions containing them
US5583135A (en) Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
US5532258A (en) H2 -receptor antagonist thiazoles
US4411900A (en) Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
PT95317A (pt) Processo para a obtencao de um novo composto tiazol destinado
WO1997029111A1 (en) New cephem compounds and pharmaceutical use thereof
CA2214521A1 (en) Quinoline derivatives as immunomodulators
WO1994029295A1 (en) Heterocyclic derivatives with immunomodulating activity
JPH07224040A (ja) キノリン誘導体
US5401737A (en) Tricyclic compounds
WO1995018126A1 (en) Furylthiazole and their use as h2-receptor antagonism and antimicrobial
CA2105981A1 (en) Thiazole derivatives
WO1996005187A1 (en) (4-(3-aminomethylphenyl)thiazol-2-yl)-guanidines as h2-receptor antagonists
JPH072873A (ja) 三環式化合物
GB2031413A (en) 3,7-Disubstituted-3-cephem-4- carboxylic Acid Compounds and Processes for the Preparation Thereof
CA2246321A1 (en) New cephem compounds and pharmaceutical use thereof
AU1618397A (en) New cephem compounds and pharmaceutical use thereof

Legal Events

Date Code Title Description
FZDE Discontinued